SanofiSNYNASDAQ
Loading
EV to Sales HistoryNormalizing
Percentile Rank14
3Y CAGR-4.2%
5Y CAGR-2.6%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
-4.2%/yr
vs -1.1%/yr prior
5Y CAGR
-2.6%/yr
Consistent
Acceleration
-3.1pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
4 yr
Consecutive declineNormalizing
PeriodValueYoY Change
20252.64-8.6%
20242.89-2.8%
20232.97-1.1%
20223.00-4.6%
20213.15+4.8%
20203.00-12.1%
20193.42+8.7%
20183.14+19.2%
20172.64-14.7%
20163.09-